United States · 
Who invested in BioBots?
BioBots's investors include Ben Franklin Technology Partners, 500 Global, FundersClub and Dreamit Ventures.
2015
$50KSeed$250KSeed$1.3MSeedUnited States · Seed startup
Who invested in BioBots
3 rounds we have observed, with the 4 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Follow BioBots and see its new rounds in your feed.Start following
Funding summaryUpdated 31 Oct 2026
$1.6Mraised across 3 rounds since 2014, from 3 sources
$50KSeed$250KSeed$1.3MSeed
- Latest round
- Seed, $1.3MSept 2015
- Step-upi
- 5×
- Investors
- 4
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Seed, $50K Nov 2014
- Biggest round
- $1.3M Seed · Sept 2015
- Usual gap between rounds
- 6 months the median of 2
The rounds
- Sept 2015Seed$1.3M3 new1 returning
From a historical funding recordSEC filing: $877K sold, first sale Jul 2015
- May 2015Seed$250K1 returning
From a historical funding recordSEC filing: $877K sold, first sale Jul 2015
- Nov 2014
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
Missing a round, or an investor who was in one? Tell us.
Quick answers about BioBots
How much has BioBots raised?
BioBots has raised $1.6M across 3 rounds since 2014.
When did BioBots last raise?
BioBots's most recent round was a Seed of $1.3M in Sept 2015.
What was BioBots's biggest round?
Its most recent round, $1.3M in Sept 2015, is also its largest on record.
Who backed BioBots first?
BioBots's first round on record, in Nov 2014, was backed by Ben Franklin Technology Partners.
What stage is BioBots at?
BioBots's latest named round is a Seed, in Sept 2015.
Where is BioBots based?
BioBots is based in the United States.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.